Global leader in
Health Sciences M&A

View Recent Transactions

Our sole focus on the Health Sciences and Pharma Services empowers us to execute more industry-transactions than competitors 10x our size.

No. 1

Advisory for
Pharma Services M&A

Top 10

In Pharma IT M&A

60+

Health Sciences-Focused Professionals

(Source: Industry Genome. Announced or Completed Transactions.)

Latest Transactions
Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities

Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities
Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network

Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network
Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network

Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network
BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering

BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering
Myonex Acquired Creapharm's Clinical & Commercial Packaging and Bioservices Business Units to Expand Clinical Trial Supply Services and Gain of Foothold in Europe

Myonex Acquired Creapharm's Clinical & Commercial Packaging and Bioservices Business Units to Expand Clinical Trial Supply Services and Gain of Foothold in Europe
Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US

Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US
Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions

Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions
physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research

physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research
Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities

Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities
Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally

Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally
Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room Manufacturing Capabilities and Expand Overall Offering

Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room Manufacturing Capabilities and Expand Overall Offering
Alpha IRB Acquired by Sabai Global, a Portfolio Company of Thompson Street Capital, to Expand IRB Capabilities

Alpha IRB Acquired by Sabai Global, a Portfolio Company of Thompson Street Capital, to Expand IRB Capabilities
Versiti Acquired Pearl Pathways to Expand Clinical Trial Services Capabilities

Versiti Acquired Pearl Pathways to Expand Clinical Trial Services Capabilities
VaxTRIALS Acquired by Emmes, a portfolio company of New Mountain Capital, to Expand Vaccine and Clinical Trial Site Capabilities

VaxTRIALS Acquired by Emmes, a portfolio company of New Mountain Capital, to Expand Vaccine and Clinical Trial Site Capabilities
Grant Avenue Capital Recapitalizes CREO

Grant Avenue Capital Recapitalizes CREO
Monroe Biomedical Research Acquired by New Harbor Capital in a First Step to Build-out a Clinical Research Site Platform

Monroe Biomedical Research Acquired by New Harbor Capital in a First Step to Build-out a Clinical Research Site Platform
SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand Into the EU

SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand Into the EU
QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally

QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally
Catalyst Clinical Research, a Portfolio Company of QHP Capital, Acquired Genpro Research to Expand Global Footprint and Deepen Service Offerings

Catalyst Clinical Research, a Portfolio Company of QHP Capital, Acquired Genpro Research to Expand Global Footprint and Deepen Service Offerings
Accel Research Sites Network Acquired by Alcanza Clinical Research, a portfolio company of Martis Capital, to Expand its Clinical Trial Site Network and Clinical Trial Execution Capabilities

Accel Research Sites Network Acquired by Alcanza Clinical Research, a portfolio company of Martis Capital, to Expand its Clinical Trial Site Network and Clinical Trial Execution Capabilities
View all deals

What We Do

We empower founders, investors, and operators to confidently connect with leading health sciences companies, align interests, and optimize outcomes. 

M&A Advisory

Investment Banking Services

As a global M&A advisory firm, we're integral to the industries we serve. Our experienced senior bankers, with deep professional relationships and knowledge, deliver services tailored to our core industry focus.

Learn More
Value Creation Servicesv2

Strategic Advisory & Origination Services

We go beyond value creation. Achieve greater outcomes with our strategic advisory and origination services. 

Learn More
Recapitaliztion

Recapitalization Services

Our deep industry understanding allows us to align growth-oriented companies with financial partners who share a common strategic vision and growth objectives.

Learn More

Our Focus

Our experienced senior bankers have spent their careers developing deep professional relationships and building in-depth knowledge of the companies, trends and insights relevant to the Health Science industry.

Pharma Services

We cover the entire Pharmaceutical Services industry, from development through commercialization

Learn More

Diagnostics & Tools

Our extensive industry experience spans routine chemistries to the most esoteric of testing

Learn More

Healthcare Technology

We are one of the handful of M&A firms with dedicated coverage to this rapidly shifting area

Learn More

Featured Insights

/ 6